Royalty Pharma Announces Pricing of Initial Public Offering

Follow Cabrera on LinkedIn

(312) 236-8888

About Us
Public Finance
Corporate Finance
Advisory
Sales & Trading
Cash Management
Real Estate

Royalty Pharma Announces Pricing of Initial Public Offering

Read Article

227 W. Monroe Street, Suite 3000 Chicago, IL 60606

(312) 236-8888

(312) 236-8936

info@cabreracapital.com

Stay Connected

The content is developed from sources believed to be providing accurate information. The information in this material is not intended as tax or legal advice. Please consult legal or tax professionals for specific information regarding your individual situation. The opinions expressed and material provided are for general information, and should not be considered a solicitation for the purchase or sale of any security.

We take protecting your data and privacy very seriously. As of January 1, 2020 the California Consumer Privacy Act (CCPA) suggests the following link as an extra measure to safeguard your data: Do not sell my personal information.

The firm does not have client order flow that requires reporting under SEC Rule 606a(1).

MSRB Disclosure

Cabrera Capital Markets is registered with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board; and

The MSRB makes available an investor brochure that is posted on the website of the Municipal Securities Rulemaking Board at www.msrb.org that describes the protections that may be provided by the Municipal Securities Rulemaking Board rules and how to file a complaint with an appropriate regulatory authority.

Check the background of your financial professional on:

FINRA’s BrokerCheck

WebAccess

Business Continuity Plan

Menu